March 28, 2024 21:03 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Comments on our electoral, legal processes completely unacceptable: India on US' remarks over Kejriwal arrest | Delhi High Court rejects PIL seeking removal of Arvind Kejriwal as CM | MHA extends AFSPA in 3 districts of Arunachal Pradesh for 6 months | Encourage fair, transparent and legal process: US comments again on Kejriwal's arrest | India and China discuss border disengagement: EAM

Infosys Foundation invests in cancer research through fellowships at Tata Memorial Centre

India Blooms News Service | | 25 Apr 2016, 07:12 pm
Bangalore, Apr 25 (IBNS): Infosys Foundation, the philanthropic arm of Infosys, has signed a Memorandum of Understanding (MoU) with Tata Memorial Centre (TMC) with the objective of developing a team of clinician-scientists proficient in translational laboratory research who will be able to bring their cross-disciplinary capabilities to bear on topical questions of cancer research in India.
According to the MoU, INR 5 Crore will be provided towards corpus funding of the Infosys Foundation Fellowships along with INR 40 Lakh towards the implementation of activities in 2016. 
 
A minimum of 2-5 young medical faculty members and oncology trainees of TMC will benefit from the endowment annually. The young trainees, identified as Infosys Fellows, will be trained at world renowned research institutions with whom the Centre has existing agreements. On their return, these individuals will be able to immediately put their research training into practice.
 
The Foundation acknowledges the excellent infrastructure and clinical material of TMC and its robust intramural program that supports research, and intends to support and build a team of young researchers invested in addressing India’s healthcare challenges.
 
Through the agreement, the Foundation will partner with TMC to fulfill their shared long-term goal of creating a cadre of clinician-scientists who will be able to undertake locally relevant innovative clinical research that will result in feasible and cost-effective treatments of common and unique Indian cancers.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.